{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:53:25Z","timestamp":1790128405228,"version":"4.0.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T00:00:00Z","timestamp":1453939200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Gilead Sciences GmbH","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s10620-015-4027-8","type":"journal-article","created":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T08:56:46Z","timestamp":1453971406000},"page":"3072-3083","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France"],"prefix":"10.1007","volume":"61","author":[{"given":"Patrick","family":"Marcellin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Zoulim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"H\u00e9zode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Causse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gine","family":"Truchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Pauwels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Ouzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Dumortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges-Philippe","family":"Pageaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bourli\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghassan","family":"Riachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Zarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Cadranel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Tilliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"P\u00e9tour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Libert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silla M.","family":"Consoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Larrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,28]]},"reference":[{"key":"4027_CR1","unstructured":"World Health Organization. Hepatitis B Fact Sheet No 204. Updated July 2014. \n                        http:\/\/www.who.int\/mediacentre\/factsheets\/fs204\/en\/\n                        \n                    . Accessed June 2015."},{"key":"4027_CR2","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/eurpub\/cks067","volume":"23","author":"JJ Chu","year":"2013","unstructured":"Chu JJ, W\u00f6rmann T, Popp J, et al. Changing epidemiology of hepatitis B and migration\u2014a comparison of six Northern and North-Western European countries. Eur J Public Health. 2013;23:642\u2013647.","journal-title":"Eur J Public Health"},{"key":"4027_CR3","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0755-4982(06)74575-4","volume":"35","author":"JP Zarski","year":"2006","unstructured":"Zarski JP. Epid\u00e9miologie de l\u2019h\u00e9patite chronique B. Presse Med. 2006;35:304\u2013307.","journal-title":"Presse Med"},{"key":"4027_CR4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jhep.2007.09.010","volume":"48","author":"P Marcellin","year":"2008","unstructured":"Marcellin P, Pequignot F, Delarocque-Astagneau E, et al. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption. J Hepatol. 2008;48:200\u2013207.","journal-title":"J Hepatol"},{"key":"4027_CR5","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1111\/j.1572-0241.2006.00647.x","volume":"101","author":"G Chen","year":"2006","unstructured":"Chen G, Lin W, Shen F, Iloeje UH, London WT, Evans AA. Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study. Am J Gastroenterol. 2006;101:1797\u20131803.","journal-title":"Am J Gastroenterol"},{"key":"4027_CR6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","volume":"295","author":"CJ Chen","year":"2006","unstructured":"Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65\u201373.","journal-title":"JAMA"},{"key":"4027_CR7","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","volume":"130","author":"UH Iloeje","year":"2006","unstructured":"Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology. 2006;130:678\u2013686.","journal-title":"Gastroenterology"},{"key":"4027_CR8","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.cgh.2007.06.015","volume":"5","author":"UH Iloeje","year":"2007","unstructured":"Iloeje UH, Yang HI, Jen CL, et al. Risk and predictors of mortality associated with chronic hepatitis B infection. Clin Gastroenterol Hepatol. 2007;5:921\u2013931.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4027_CR9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","volume":"57","author":"European Association for the Study of the Liver","year":"2012","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol. 2012;57:167\u2013185.","journal-title":"J Hepatol"},{"key":"4027_CR10","unstructured":"Dhumeaux D. Prise en charge des personnes infect\u00e9es par les virus de l\u2019h\u00e9patite B ou de l\u2019h\u00e9patite C. Rapport de Recommandations 2014. \n                        http:\/\/www.sante.gouv.fr\/IMG\/pdf\/Rapport_Prise_en_charge_Hepatites_2014.pdf\n                        \n                    . Accessed June 2015."},{"key":"4027_CR11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","volume":"50","author":"AS Lok","year":"2009","unstructured":"Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50:661\u2013662.","journal-title":"Hepatology"},{"key":"4027_CR12","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa0802878","volume":"359","author":"P Marcellin","year":"2008","unstructured":"Marcellin P, Heathcote EJ, Buti M, et al. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N Engl J Med. 2008;359:2442\u20132455.","journal-title":"N Engl J Med"},{"key":"4027_CR13","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1053\/j.gastro.2010.10.011","volume":"140","author":"EJ Heathcote","year":"2011","unstructured":"Heathcote EJ, Marcellin P, Buti M, et al. Three-year efficacy and safety of tenofovir disoproxil fumarate treatment for chronic hepatitis B. Gastroenterology. 2011;140:132\u2013143.","journal-title":"Gastroenterology"},{"key":"4027_CR14","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","volume":"381","author":"P Marcellin","year":"2013","unstructured":"Marcellin P, Gane E, Buti M, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet. 2013;381:468\u2013475.","journal-title":"Lancet"},{"key":"4027_CR15","doi-asserted-by":"crossref","first-page":"313A","DOI":"10.1002\/hep.27486","volume":"60","author":"P Marcellin","year":"2014","unstructured":"Marcellin P, Gane EJ, Flisiak R, et al. Long term treatment with tenofovir disoproxil fumarate for chronic hepatitis B infection is safe and well tolerated and associated with durable virologic response with no detectable resistance: 8\u00a0year results from two phase 3 trials. Hepatology. 2014;60:313A.","journal-title":"Hepatology"},{"key":"4027_CR16","first-page":"653A","volume":"58","author":"P Lampertico","year":"2013","unstructured":"Lampertico P, Soffrendi R, Yurdaydin C, et al. Four years of tenofovir monotherapy for NUC na\u00efve field practice European patients suppresses HBV replication in most patients with a favourable renal safety profile but does not prevent HCC in patients with or without cirrhosis. Hepatology. 2013;58:653A.","journal-title":"Hepatology"},{"key":"4027_CR17","first-page":"S544","volume":"57","author":"F B\u00f6mmel van","year":"2012","unstructured":"van B\u00f6mmel F, Zoutendijk R, de Man R, et al. A European field study of the efficacy and safety of tenofovir disoproxil fumarate (TDF) monotherapy in patients with prior failure to other nucleoside\/nucleotide analogues. J Hepatol. 2012;57:S544.","journal-title":"J Hepatol"},{"key":"4027_CR18","first-page":"1044","volume":"30","author":"X Girerd","year":"2001","unstructured":"Girerd X, Hanon O, Anagnostopoulos K, Ciupek C, Mourad JJ, Consoli S. Assessment of antihypertensives compliance using a self-administered questionnaire: development and use in hypertension clinics. Presse Med. 2001;30:1044\u20131048.","journal-title":"Presse Med"},{"key":"4027_CR19","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1053\/j.gastro.2010.06.053","volume":"139","author":"T Berg","year":"2010","unstructured":"Berg T, Marcellin P, Zoulim F, et al. Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection. Gastroenterology. 2010;139:1207\u20131217.","journal-title":"Gastroenterology"},{"key":"4027_CR20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.23246","volume":"51","author":"F B\u00f6mmel van","year":"2010","unstructured":"van B\u00f6mmel F, de Man RA, Wedemeyer H, et al. Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside\/nucleotide analogues. Hepatology. 2010;51:73\u201380.","journal-title":"Hepatology"},{"key":"4027_CR21","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","volume":"351","author":"YF Liaw","year":"2004","unstructured":"Liaw YF, Sung JJ, Chow WC, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004;351:1521\u20131531.","journal-title":"N Engl J Med"},{"key":"4027_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfq128","volume":"116","author":"E Lock","year":"2010","unstructured":"Lock E. Sensitive and early markers of renal injury: where are we and what is the way forward? Toxicol Sci. 2010;116:1\u20134.","journal-title":"Toxicol Sci"},{"key":"4027_CR23","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/cid\/cit601","volume":"57","author":"L Wang","year":"2013","unstructured":"Wang L, Kourtis AP, Ellington S, Legardy-Williams J, Bulterys M. Safety of tenofovir during pregnancy for the mother and fetus: a systematic review. Clin Infect Dis. 2013;57:1773\u20131781.","journal-title":"Clin Infect Dis"},{"issue":"Suppl","key":"4027_CR24","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1002\/hep.22885","volume":"49","author":"RJ Fontana","year":"2009","unstructured":"Fontana RJ. Side effects of long-term oral antiviral therapy for hepatitis B. Hepatology. 2009;49(Suppl):S185\u2013S195.","journal-title":"Hepatology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-015-4027-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-4027-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-4027-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-015-4027-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T19:07:59Z","timestamp":1553627279000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-015-4027-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,28]]},"references-count":24,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["4027"],"URL":"https:\/\/doi.org\/10.1007\/s10620-015-4027-8","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,28]]}}}